Does Freeline Therapeutics Holdings PLC (FRLN) Have What it Takes to be in Your Portfolio Wednesday?

Wednesday, October 04, 2023 10:55 AM | InvestorsObserver Analysts

Mentioned in this article

Does Freeline Therapeutics Holdings PLC (FRLN) Have What it Takes to be in Your Portfolio Wednesday?

A rating of 73 puts Freeline Therapeutics Holdings PLC (FRLN) near the top of the Biotechnology industry according to InvestorsObserver. Freeline Therapeutics Holdings PLC's score of 73 means it scores higher than 73% of stocks in the industry. Freeline Therapeutics Holdings PLC also received an overall rating of 54, putting it above 54% of all stocks. Biotechnology is ranked 73 out of the 148 industries.

FRLN has an Overall Score of 54. Find out what this means to you and get the rest of the rankings on FRLN!

See Full FRLN Report

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts. These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Freeline Therapeutics Holdings PLC Stock Today?

Freeline Therapeutics Holdings PLC (FRLN) stock is higher by 6.39% while the S&P 500 is down -0.06% as of 10:55 AM on Wednesday, Oct 4. FRLN has gained $0.24 from the previous closing price of $3.76 on volume of 8,439,095 shares. Over the past year the S&P 500 is higher by 11.50% while FRLN is down -62.96%. FRLN lost -$182.56 per share the over the last 12 months. Click Here to get the full Stock Report for Freeline Therapeutics Holdings PLC stock.